U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Maplirpacept
INN  
Official Name English
1-118-Signal regulatory protein α (human) fusion protein with immunoglobulin G4 [128-proline] (human γ4-chain C region C-terminal fragment), dimer
Common Name English
maplirpacept [INN]
Common Name English
TTI-622
Code English
TTI 622 [WHO-DD]
Common Name English
TTI622
Code English
SIRPA-IGG4-FC FUSION PROTEIN TTI-622
Common Name English
PF-07901801
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 858521
Created by admin on Sat Dec 16 14:44:39 GMT 2023 , Edited by admin on Sat Dec 16 14:44:39 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C150756
Created by admin on Sat Dec 16 14:44:39 GMT 2023 , Edited by admin on Sat Dec 16 14:44:39 GMT 2023
PRIMARY NCIT
FDA UNII
44D51T6SZH
Created by admin on Sat Dec 16 14:44:39 GMT 2023 , Edited by admin on Sat Dec 16 14:44:39 GMT 2023
PRIMARY
CAS
2631667-06-4
Created by admin on Sat Dec 16 14:44:39 GMT 2023 , Edited by admin on Sat Dec 16 14:44:39 GMT 2023
PRIMARY
INN
12295
Created by admin on Sat Dec 16 14:44:39 GMT 2023 , Edited by admin on Sat Dec 16 14:44:39 GMT 2023
PRIMARY
ACTIVE MOIETY
Maplirpacept
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966